Ventas VTR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Ventas (VTR) Business Model and Operations Summary
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Key Insights
Ventas (VTR) Core Market Data and Business Metrics
Latest Closing Price
$69.27Market Cap
$30.32 BillionPrice-Earnings Ratio
364.58Total Outstanding Shares
437.62 Million SharesTotal Employees
498Dividend
$0.48 Per Share QuarterlyIPO Date
May 5, 1997SIC Description
Real Estate Investment TrustsPrimary Exchange
New York Stock ExchangeHeadquarters
300 N Lasalle Street, Chicago, IL, 60654
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $397.76 Million |
| Net Cash Flow From Financing Activities, Continuing | $1.45 Billion |
| Exchange Gains/Losses | $-3.98 Million |
| Net Cash Flow From Operating Activities, Continuing | $1.33 Billion |
| Net Cash Flow | $393.77 Million |
| Net Cash Flow From Investing Activities, Continuing | $-2.38 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss | $88.35 Million |
| Income/Loss From Continuing Operations After Tax | $29.78 Million |
| Diluted Average Shares | $416.37 Million |
| Basic Average Shares | $411.77 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $7.20 Million |
| Operating Income/Loss | $-8.00 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $82.25 Million |
| Comprehensive Income/Loss Attributable To Parent | $83.39 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-1.14 Million |
| Other Comprehensive Income/Loss | $-6.10 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $58.33 Million |
| Assets | $26.19 Billion |
| Temporary Equity | $310.23 Million |
| Current Assets | $26.19 Billion |
| Long-term Debt | $13.52 Billion |
| Accounts Receivable | $108.14 Million |
Historical Dividends
Current dividend: $0.48 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 12, 2025 | Apr 17, 2025 | Mar 31, 2025 | $0.48 | Quarterly |
| Dec 10, 2024 | Jan 16, 2025 | Dec 31, 2024 | $0.45 | Quarterly |
| Sep 17, 2024 | Oct 17, 2024 | Oct 1, 2024 | $0.45 | Quarterly |
| May 14, 2024 | Jul 18, 2024 | Jul 1, 2024 | $0.45 | Quarterly |
| Mar 12, 2024 | Apr 18, 2024 | Apr 1, 2024 | $0.45 | Quarterly |
| Dec 5, 2023 | Jan 18, 2024 | Jan 2, 2024 | $0.45 | Quarterly |